These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

636 related items for PubMed ID: 23539110

  • 1. IMPROVE trial: a randomized controlled trial of patient-controlled analgesia for sickle cell painful episodes: rationale, design challenges, initial experience, and recommendations for future studies.
    Dampier CD, Smith WR, Wager CG, Kim HY, Bell MC, Miller ST, Weiner DL, Minniti CP, Krishnamurti L, Ataga KI, Eckman JR, Hsu LL, McClish D, McKinlay SM, Molokie R, Osunkwo I, Smith-Whitley K, Telen MJ, Sickle Cell Disease Clinical Research Network (SCDCRN).
    Clin Trials; 2013 Apr; 10(2):319-31. PubMed ID: 23539110
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
    van Beers EJ, van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ.
    Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
    [Abstract] [Full Text] [Related]

  • 5. Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial.
    Rees CA, Brousseau DC, Cohen DM, Villella A, Dampier C, Brown K, Campbell A, Chumpitazi CE, Airewele G, Chang T, Denton C, Ellison A, Thompson A, Ahmad F, Bakshi N, Coleman KD, Leibovich S, Leake D, Hatabah D, Wilkinson H, Robinson M, Casper TC, Vichinsky E, Morris CR, SCD Arginine Study Group and PECARN.
    Trials; 2023 Aug 17; 24(1):538. PubMed ID: 37587492
    [Abstract] [Full Text] [Related]

  • 6. Sickle cell disease patients and patient-controlled analgesia.
    Johnson L.
    Br J Nurs; 2023 Aug 17; 12(3):144-53. PubMed ID: 12610369
    [Abstract] [Full Text] [Related]

  • 7. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD).
    Tanabe P, Silva S, Bosworth HB, Crawford R, Paice JA, Richardson LD, Miller CN, Glassberg J.
    Am J Hematol; 2018 Feb 17; 93(2):159-168. PubMed ID: 29047145
    [Abstract] [Full Text] [Related]

  • 8. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    Casella JF, Barton BA, Kanter J, Black LV, Majumdar S, Inati A, Wali Y, Drachtman RA, Abboud MR, Kilinc Y, Fuh BR, Al-Khabori MK, Takemoto CM, Salman E, Sarnaik SA, Shah N, Morris CR, Keates-Baleeiro J, Raj A, Alvarez OA, Hsu LL, Thompson AA, Sisler IY, Pace BS, Noronha SA, Lasky JL, de Julian EC, Godder K, Thornburg CD, Kamberos NL, Nuss R, Marsh AM, Owen WC, Schaefer A, Tebbi CK, Chantrain CF, Cohen DE, Karakas Z, Piccone CM, George A, Fixler JM, Singleton TC, Moulton T, Quinn CT, de Castro Lobo CL, Almomen AM, Goyal-Khemka M, Maes P, Emanuele M, Gorney RT, Padgett CS, Parsley E, Kronsberg SS, Kato GJ, Gladwin MT.
    JAMA; 2021 Apr 20; 325(15):1513-1523. PubMed ID: 33877274
    [Abstract] [Full Text] [Related]

  • 9. Patient-controlled analgesia with remifentanil versus alternative parenteral methods for pain management in labour.
    Weibel S, Jelting Y, Afshari A, Pace NL, Eberhart LH, Jokinen J, Artmann T, Kranke P.
    Cochrane Database Syst Rev; 2017 Apr 13; 4(4):CD011989. PubMed ID: 28407220
    [Abstract] [Full Text] [Related]

  • 10. Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial.
    Barrett MJ, Cronin J, Murphy A, McCoy S, Hayden J, an Fhailí S, Grant T, Wakai A, McMahon C, Walsh S, O'Sullivan R.
    Trials; 2012 May 30; 13():74. PubMed ID: 22647439
    [Abstract] [Full Text] [Related]

  • 11. Impact of PCA strategies on pain intensity and functional assessment measures in adults with sickle cell disease during hospitalized vaso-occlusive episodes.
    Dampier CD, Wager CG, Harrison R, Hsu LL, Minniti CP, Smith WR, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).
    Am J Hematol; 2012 Oct 30; 87(10):E71-4. PubMed ID: 22886853
    [Abstract] [Full Text] [Related]

  • 12. Clinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trial.
    Peters-Lawrence MH, Bell MC, Hsu LL, Osunkwo I, Seaman P, Blackwood M, Guillaume E, Bellevue R, Krishnamurti L, Smith WR, Dampier CD, Minniti CP, Sickle Cell Disease Clinical Research Network (SCDCRN).
    Contemp Clin Trials; 2012 Mar 30; 33(2):291-7. PubMed ID: 22155024
    [Abstract] [Full Text] [Related]

  • 13. Pain experience of children with sickle cell disease who had prolonged hospitalizations for acute painful episodes.
    Jacob E, Mueller BU.
    Pain Med; 2008 Mar 30; 9(1):13-21. PubMed ID: 18254762
    [Abstract] [Full Text] [Related]

  • 14. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
    Nottage KA, Hankins JS, Faughnan LG, James DM, Richardson J, Christensen R, Kang G, Smeltzer M, Cancio MI, Wang WC, Anghelescu DL.
    Clin Trials; 2016 Aug 30; 13(4):409-16. PubMed ID: 27000103
    [Abstract] [Full Text] [Related]

  • 15. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N, Floroff C, Hassig TB, Boylan A, Kanter J.
    J Pain Palliat Care Pharmacother; 2018 Mar 30; 32(1):20-26. PubMed ID: 29791238
    [Abstract] [Full Text] [Related]

  • 16. Pain management in children with sickle cell disease.
    Stinson J, Naser B.
    Paediatr Drugs; 2003 Mar 30; 5(4):229-41. PubMed ID: 12662119
    [Abstract] [Full Text] [Related]

  • 17. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
    Lubega FA, DeSilva MS, Munube D, Nkwine R, Tumukunde J, Agaba PK, Nabukenya MT, Bulamba F, Luggya TS.
    Scand J Pain; 2018 Jan 26; 18(1):19-27. PubMed ID: 29794277
    [Abstract] [Full Text] [Related]

  • 18. The future of Cochrane Neonatal.
    Soll RF, Ovelman C, McGuire W.
    Early Hum Dev; 2020 Nov 26; 150():105191. PubMed ID: 33036834
    [Abstract] [Full Text] [Related]

  • 19. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
    Buchanan ID, Woodward M, Reed GW.
    Pediatr Blood Cancer; 2005 Oct 15; 45(5):716-24. PubMed ID: 15926170
    [Abstract] [Full Text] [Related]

  • 20. Trial design of comparing patient-specific versus weight-based protocols to treat vaso-occlusive episodes in sickle cell disease (COMPARE-VOE).
    Ibemere SO, Dubbs SB, Barnhart HX, Brown JL, Freiermuth CE, Kavanagh P, Paice JA, Strouse JJ, Wilkerson RG, Tanabe P, COMPARE-VOE study investigators.
    Contemp Clin Trials; 2021 Feb 15; 101():106252. PubMed ID: 33348066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.